NCT01833585View on ClinicalTrials.gov

Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells

PHASE3CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Critical Limb IschemiaAtherosclerosisIschemic UlcerGangrene
Interventions
BIOLOGICAL

Peripheral blood mononuclear cell

Peripheral blood mononuclear cell solution 59 cc will be injected to the gastrocnemius muscle of ischemic limb of patients with critical limb ischemia

Trial Locations (1)

10700

Vascular Surgery, Siriraj Hospital, Mahidol University, Bangkoknoi

All Listed Sponsors
lead

Mahidol University

OTHER

NCT01833585 - Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells | Biotech Hunter | Biotech Hunter